Evidence map›Paper›PMID 27231330›Full record

ArticleMolecular pharmacology2016

Glutamate Delta-1 Receptor Regulates Metabotropic Glutamate Receptor 5 Signaling in the Hippocampus.

Pratyush S Suryavanshi, Subhash C Gupta, Roopali Yadav, Varun Kesherwani, Jinxu Liu, Shashank M Dravid

Open access · bronzeAbstract read
In one paragraph

Article in Molecular pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Glutamate Delta 1 Receptor in Synapses, Circuits, and Disease.The European journal of neuroscience · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. A GluD Coming-Of-Age Story.Trends in neurosciences · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Pratyush S SuryavanshiDepartment of Pharmacology, Creighton University, Omaha, Nebraska.
Subhash C GuptaDepartment of Pharmacology, Creighton University, Omaha, Nebraska.
Roopali YadavDepartment of Pharmacology, Creighton University, Omaha, Nebraska.
Varun KesherwaniDepartment of Pharmacology, Creighton University, Omaha, Nebraska.
Jinxu LiuDepartment of Pharmacology, Creighton University, Omaha, Nebraska.
Shashank M DravidDepartment of Pharmacology, Creighton University, Omaha, Nebraska ShashankDravid@creighton.edu.
Creighton University · US

Funding

Assessment of glutamate delta-1 receptor in mental disordersR21MH098270 · NIMH · CREIGHTON UNIVERSITY · PI DRAVID, SHASHANK MANOHAR · 2013 to 2014
$400k
NIMH NIH HHS R21 MH098270
6 · The paper itself

Abstract

The delta family of ionotropic glutamate receptors consists of glutamate delta-1 (GluD1) and glutamate delta-2 receptors. We have previously shown that GluD1 knockout mice exhibit features of developmental delay, including impaired spine pruning and switch in the N-methyl-D-aspartate receptor subunit, which are relevant to autism and other neurodevelopmental disorders. Here, we identified a novel role of GluD1 in regulating metabotropic glutamate receptor 5 (mGlu5) signaling in the hippocampus. Immunohistochemical analysis demonstrated colocalization of mGlu5 with GluD1 punctas in the hippocampus. Additionally, GluD1 protein coimmunoprecipitated with mGlu5 in the hippocampal membrane fraction, as well as when overexpressed in human embryonic kidney 293 cells, demonstrating that GluD1 and mGlu5 may cooperate in a signaling complex. The interaction of mGlu5 with scaffold protein effector Homer, which regulates mechanistic target of rapamycin (mTOR) signaling, was abnormal both under basal conditions and in response to mGlu1/5 agonist (RS)-3,5-dihydroxyphenylglycine (DHPG) in GluD1 knockout mice. The basal levels of phosphorylated mTOR and protein kinase B, the signaling proteins downstream of mGlu5 activation, were higher in GluD1 knockout mice, and no further increase was induced by DHPG. We also observed higher basal protein translation and an absence of DHPG-induced increase in GluD1 knockout mice. In accordance with a role of mGlu5-mediated mTOR signaling in synaptic plasticity, DHPG-induced internalization of surface α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor subunits was impaired in the GluD1 knockout mice. These results demonstrate that GluD1 interacts with mGlu5, and loss of GluD1 impairs normal mGlu5 signaling potentially by dysregulating coupling to its effector. These studies identify a novel role of the enigmatic GluD1 subunit in hippocampal function.

Indexed as

AnimalsGene DeletionHippocampusImmunoprecipitationMice, KnockoutModels, BiologicalPhosphorylationProtein BindingProtein IsoformsProto-Oncogene Proteins c-aktReceptor, Metabotropic Glutamate 5Receptors, GlutamateReceptors, Metabotropic GlutamateSignal TransductionTOR Serine-Threonine Kinasesglutamate receptor delta 1Protein IsoformsProto-Oncogene Proteins c-aktReceptor, Metabotropic Glutamate 5Receptors, GlutamateReceptors, Metabotropic GlutamateTOR Serine-Threonine Kinases

Identifiers

PMID27231330
PMCPMC4959088
OpenAlexW2400802556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.